Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults
about
sameAs
Neuroimmune endocrine effects of antidepressantsMelatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.Agomelatine as monotherapy for major depression: an outpatient, open-label study.Agomelatine: A novel melatonergic antidepressant.Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction
P2860
Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Critical appraisal and update ...... r depressive disease in adults
@ast
Critical appraisal and update ...... r depressive disease in adults
@en
Critical appraisal and update ...... r depressive disease in adults
@nl
type
label
Critical appraisal and update ...... r depressive disease in adults
@ast
Critical appraisal and update ...... r depressive disease in adults
@en
Critical appraisal and update ...... r depressive disease in adults
@nl
prefLabel
Critical appraisal and update ...... r depressive disease in adults
@ast
Critical appraisal and update ...... r depressive disease in adults
@en
Critical appraisal and update ...... r depressive disease in adults
@nl
P2860
P1476
Critical appraisal and update ...... r depressive disease in adults
@en
P2093
Robert H Howland
P2860
P304
P407
P577
2009-01-01T00:00:00Z